Fencamfamin
Fencamfamin
Fencamfamin (pronounced fen-kam-fa-min) is a stimulant drug that was developed in the 1960s for potential use in treating conditions such as obesity and hyperactivity. It is a member of the amphetamine family of drugs, specifically a derivative of methamphetamine.
Etymology
The name "Fencamfamin" is derived from the chemical structure of the drug, which is a phenyl ring (fen-) attached to a camphor backbone (-cam-) with an amine group (-famin).
Pharmacology
Fencamfamin acts as a norepinephrine-dopamine reuptake inhibitor (NDRI), increasing the levels of these neurotransmitters in the brain. This results in increased alertness, focus, and energy, similar to other stimulants.
Medical Use
Fencamfamin was initially developed for use in treating obesity due to its appetite-suppressing effects. However, due to concerns about potential for abuse and addiction, it was never widely used for this purpose. It has also been investigated for potential use in treating attention deficit hyperactivity disorder (ADHD), but again, concerns about potential for abuse have limited its use.
Related Terms
- Stimulant
- Amphetamine
- Methamphetamine
- Norepinephrine-dopamine reuptake inhibitor
- Obesity
- Hyperactivity
External links
- Medical encyclopedia article on Fencamfamin
- Wikipedia's article - Fencamfamin
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski